Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued response to standard antiplatelet agents may explain high rate of adverse cardiovascular events in patients with DM. Several antithrombotic treatment strategies have been developed to control the prothrombotic state in patients with DM: dose modification of commonly used agents; use of potent agents; and addition of a third antithrombotic drug (triple therapy) to commonly prescribed dual antiplatelet therapy of aspirin and a P2Y₁₂ inhibitor. The present review aims to provide an overview of the current knowledge on platelet abnormalities in patients with DM, focusing on the challenges and perspectives of antiplatelet treatment strategies in this population.

Citations

Citations to this article as recorded by  

• Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasis
  Woosuk S. Hur, Tomohiro Kawano, Jean Marie N. Mwiza, David S. Paul, Robert H. Lee, Emily G. Clark, Emma G. Bouck, Ananya Dutta, Can Cai, Stephen R. Baker, Martin Guthold, Nigel Mackman, Pierre Mangin, Alisa S. Wolberg, Wolfgang Bergmeier, Matthew J. Flick
  Blood.2024; 143(2): 105.     CrossRef
• New Score Models for Predicting Bleeding and Ischemic of Ticagrelor Therapy in Patients with Diabetes Mellitus
  Xiaotong Xia, Shu Chen, Chang Cao, YanRong Ye, Yun Shen
  Clinical and Applied Thrombosis/Hemostasis.2024;[Epub]     CrossRef
• On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES
  Bahira Shahim, Björn Redfors, Thomas D. Stuckey, Mengdan Liu, Zhipeng Zhou, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz‐Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Iva Srdanovi
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
  Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
  Life.2023; 13(7): 1473.     CrossRef
• Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel
  Abdullah Alkattan, Ahmed Alkhalifah, Eman Alsalameen, Fatimah Alghanim, Nashwa Radwan
  Pharmacogenomics.2022; 23(1): 61.     CrossRef
• Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
  Seung-Jun Lee, Dong-Woo Choi, Choongki Kim, Yongsung Suh, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Eun-Cheol Park, Yangsoo Jang, Chung-Mo Nam, Myeong-Ki Hong
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials
  Victor I. Kalashnikov, Marina S. Michurova
  Terapevticheskii arkhiv.2022; 94(10): 1204.     CrossRef
• Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
  Kyeong Ho Yun, Jae Young Cho, Seung Yul Lee, Sang Jae Rhee, Byeong Keuk Kim, Myeong Ki Hong, Yangsoo Jang, Seok Kyu Oh
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Long-term outcomes of ischaemic stroke patients with diabetes in a multi-ethnic cohort in Singapore
  Ei Zune The, Mei Yen Ng, Geelyn JL Ng, Bernadette GC Er, Amy ML Quek, Prakash Paliwal, Leonard L Yeo, Bernard PL Chan, Vijay K Sharma, Hock Luen Teoh, Eric YH Khoo, Raymond CS Seet
  Annals of the Academy of Medicine, Singapore.2021; 50(1): 16.     CrossRef
• Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury
  Kornela Hałucha, Alina Rak-Pasikowska, Iwona Bil-Lula, David J. Chambers
  Cardiology Research and Practice.2021; 2021: 1.     CrossRef
• Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways
  Denise Coutinho de Miranda, Gabriela de Oliveira Faria, Milla Marques Hermidorff, Fernanda Cacilda dos Santos Silva, Leonardo Vinícius Monteiro de Assis, Mauro César Isoldi
  Current Vascular Pharmacology.2021; 19(5): 499.     CrossRef
• Post-Transcriptional Expression Control in Platelet Biogenesis and Function
  Carolin T. Neu, Tony Gutschner, Monika Haemmerle
  International Journal of Molecular Sciences.2020; 21(20): 7614.     CrossRef
• The impact of metformin and aspirin on T-cell mediated inflammation: A systematic review of in vitro and in vivo findings
  Tawanda Maurice Nyambuya, Phiwayinkosi Vusi Dludla, Vuyolwethu Mxinwa, Kabelo Mokgalaboni, Siphamandla Raphael Ngcobo, Luca Tiano, Bongani Brian Nkambule
  Life Sciences.2020; 255: 117854.     CrossRef
• Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes mellitus: A meta-analysis of randomized controlled trials
  Hongyu Zhang, Junsong Ke, Jun Huang, Kai Xu, Yun Chen, Timir Paul
  PLOS ONE.2020; 15(12): e0242845.     CrossRef
• Long non-coding RNA metallothionein 1 pseudogene 3 promotes p2y12 expression by sponging miR-126 to activate platelet in diabetic animal model
  Ming Zhou, Meng Gao, Yanwei Luo, Rong Gui, Hongwen Ji
  Platelets.2019; 30(4): 452.     CrossRef
• Circulating blood cells and extracellular vesicles in acute cardioprotection
  Sean M Davidson, Ioanna Andreadou, Lucio Barile, Yochai Birnbaum, Hector A Cabrera-Fuentes, Michael V Cohen, James M Downey, Henrique Girao, Pasquale Pagliaro, Claudia Penna, John Pernow, Klaus T Preissner, Péter Ferdinandy
  Cardiovascular Research.2019; 115(7): 1156.     CrossRef
• Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention
  Kye Taek Ahn, Seok-Woo Seong, Ung Lim Choi, Seon-Ah Jin, Jun Hyung Kim, Jae-Hwan Lee, Si Wan Choi, Myung Ho Jeong, Shung Chull Chae, Young Jo Kim, Chong Jin Kim, Hyo-Soo Kim, Myeong-Chan Cho, Hyeon-Cheol Gwon, Jin-Ok Jeong, In-Whan Seong
  Medicine.2019; 98(11): e14833.     CrossRef
• Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
  Benjamin T. Maatman, Glen Schmeisser, Rolf P. Kreutz
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention
  Eliano P. Navarese, Michalina Kołodziejczak, Aniela Petrescu, Bernhard Wernly, Michael Lichtenauer, Alexander Lauten, Antonino Buffon, Wojciech Wanha, Vincenzo Pestrichella, Gennaro Sardella, Gaetano Contegiacomo, Udaya Tantry, Kevin Bliden, Jacek Kubica,
  Expert Review of Cardiovascular Therapy.2018; 16(6): 419.     CrossRef
• Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
  Isabella Russo, Saveria Femminò, Cristina Barale, Francesca Tullio, Stefano Geuna, Franco Cavalot, Pasquale Pagliaro, Claudia Penna
  Frontiers in Physiology.2018;[Epub]     CrossRef
• Aortic thrombosis in dogs
  Trevor P.E. Williams, Scott Shaw, Adam Porter, Larry Berkwitt
  Journal of Veterinary Emergency and Critical Care.2017; 27(1): 9.     CrossRef
• Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology
  Robert A Byrne, Shmuel Banai, Roisin Colleran, Antonio Colombo
  Interventional Cardiology Review.2017; 13(01): 40.     CrossRef
• Adding CABG to the Dual Antiplatelet Salad
  Glenn N. Levine, Faisal G. Bakaeen
  Journal of the American College of Cardiology.2017; 69(2): 128.     CrossRef
• The association between arterial stiffness and tongue manifestations of blood stasis in patients with type 2 diabetes
  Po-Chi Hsu, Yu-Chuen Huang, John Y. Chiang, Hen-Hong Chang, Pei-Yung Liao, Lun-Chien Lo
  BMC Complementary and Alternative Medicine.2016;[Epub]     CrossRef
• Platelet phenotype changes associated with breast cancer and its treatment
  Chris E. Holmes, Jamie E. Levis, David J. Schneider, Nadia M. Bambace, Deva Sharma, Inder Lal, Marie E. Wood, Hyman B. Muss
  Platelets.2016; 27(7): 703.     CrossRef